$15m cap raise Fresh Equities at 24c, page-636

Well as I have said before if anyone is not offering close to $1b then they can go fishing...

Really no point..as much as the CR mucked up the momentum it also creates a future value...Now the Biotech ...if any who were interested knows that we are going alone.....they can sit on sidelines and watch the show..

I still think the results are too amazing to ignore ( especially the Prometric) and someone is going to come to the party at some stage...MD keeping it tight after one F up spill of Prof Voit...Board changes expected anytime as they suggested before the end of the year...so who is coming??

With trial delayed to 2022 @Uboy suggested may be combo trial still possible with some big Pharma...FDA announcement is due on protocol submission.

Progress of the CRO will be coming soon..

And any other unexpected news might drop in..

Anyone with any more info on webinar??

Missed this one .

IMO Dyor